These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11390010)

  • 1. Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers.
    Gemma A; Hosoya Y; Seike M; Uematsu K; Kurimoto F; Hibino S; Yoshimura A; Shibuya M; Kudoh S; Emi M
    Lung Cancer; 2001 Jun; 32(3):289-95. PubMed ID: 11390010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer.
    Gemma A; Seike M; Seike Y; Uematsu K; Hibino S; Kurimoto F; Yoshimura A; Shibuya M; Harris CC; Kudoh S
    Genes Chromosomes Cancer; 2000 Nov; 29(3):213-8. PubMed ID: 10992296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the macrophage scavenger receptor 1 (MSR1) gene in primary lung cancer.
    Yoshimura A; Gemma A; Kataoka K; Hosoya Y; Noro R; Seike M; Kokubo Y; Watanabe M; Kudoh S
    J Nippon Med Sch; 2004 Apr; 71(2):99-104. PubMed ID: 15260083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells.
    Percy MJ; Myrie KA; Neeley CK; Azim JN; Ethier SP; Petty EM
    Genes Chromosomes Cancer; 2000 Dec; 29(4):356-62. PubMed ID: 11066082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers.
    Tanaka K; Nishioka J; Kato K; Nakamura A; Mouri T; Miki C; Kusunoki M; Nobori T
    Jpn J Cancer Res; 2001 Sep; 92(9):952-8. PubMed ID: 11572763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers.
    Imai Y; Shiratori Y; Kato N; Inoue T; Omata M
    Jpn J Cancer Res; 1999 Aug; 90(8):837-40. PubMed ID: 10543255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No mutations of the Bub1 gene in human gastric and oral cancer cell lines.
    Nakagawa H; Yokozaki H; Oue N; Sugiyama M; Ishikawa T; Tahara E; Yasui W
    Oncol Rep; 2002; 9(6):1229-32. PubMed ID: 12375025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
    Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
    Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer.
    Hernando E; Orlow I; Liberal V; Nohales G; Benezra R; Cordon-Cardo C
    Int J Cancer; 2001 Jul; 95(4):223-7. PubMed ID: 11400114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human REV7 homolog that interacts with the polymerase zeta catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2.
    Murakumo Y; Roth T; Ishii H; Rasio D; Numata S; Croce CM; Fishel R
    J Biol Chem; 2000 Feb; 275(6):4391-7. PubMed ID: 10660610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLF6: mutational analysis and effect on cancer cell proliferation.
    Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
    Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promoter region of the human BUBR1 gene and its expression analysis in lung cancer.
    Seike M; Gemma A; Hosoya Y; Hosomi Y; Okano T; Kurimoto F; Uematsu K; Takenaka K; Yoshimura A; Shibuya M; Ui-Tei K; Kudoh S
    Lung Cancer; 2002 Dec; 38(3):229-34. PubMed ID: 12445743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint.
    Kim HS; Park KH; Kim SA; Wen J; Park SW; Park B; Gham CW; Hyung WJ; Noh SH; Kim HK; Song SY
    Mutat Res; 2005 Oct; 578(1-2):187-201. PubMed ID: 16112690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired BAX protein expression in breast cancer: mutational analysis of the BAX and the p53 gene.
    Sturm I; Papadopoulos S; Hillebrand T; Benter T; Lück HJ; Wolff G; Dörken B; Daniel PT
    Int J Cancer; 2000 Aug; 87(4):517-21. PubMed ID: 10918191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers.
    Takahashi T; Haruki N; Nomoto S; Masuda A; Saji S; Osada H; Takahashi T
    Oncogene; 1999 Jul; 18(30):4295-300. PubMed ID: 10439037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.
    Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ
    Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
    Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
    Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3.
    Timmer T; Terpstra P; van den Berg A; Veldhuis PM; Ter Elst A; Voutsinas G; Hulsbeek MM; Draaijers TG; Looman MW; Kok K; Naylor SL; Buys CH
    Eur J Hum Genet; 1999; 7(4):478-86. PubMed ID: 10352938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.